Top Clinical Trials companies in Denmark by Net Cash Used Provided By Financing Activities
Denmark
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 134.26 M
|
Dec. 31, 2023 | USD 96.67 | -5.32% |
|
Denmark |
|
| 2 |
USD 108.92 M
|
Dec. 31, 2023 | USD 25.56 | -6.78% |
|
Denmark |
|
| 3 |
USD 56.66 M
|
Dec. 31, 2023 | USD 88.54 | -3.65% |
|
Denmark |
|
| 4 |
USD 4.07 M
|
Dec. 31, 2023 | USD 4.38 | -2.50% |
|
Denmark |
|
| 5 |
USD 2.71 M
|
Dec. 31, 2023 | USD 1.58 | -5.64% |
|
Denmark |
|
| 6 |
USD -786.34 K
|
Dec. 31, 2023 | USD 0.73 | 4.37% |
|
Denmark |
Frequently Asked Questions
-
Which Clinical Trials company in Denmark has the highest Net Cash Used Provided By Financing Activities ?
The Clinical Trials company in Denmark with the highest Net Cash Used Provided By Financing Activities is Zealand Pharma A/S (Copenhagen Stock Exchange: ZEAL.CO) at USD 134.26 M.
-
Which Clinical Trials company in Denmark has the lowest Net Cash Used Provided By Financing Activities ?
The Clinical Trials company in Denmark with the lowest Net Cash Used Provided By Financing Activities is Saniona AB (publ) (Stockholm Stock Exchange: SANION.ST) at USD -786.34 K.
-
What are the top 10 Clinical Trials companies in Denmark by Net Cash Used Provided By Financing Activities ?
The top 10 Clinical Trials companies in Denmark by Net Cash Used Provided By Financing Activities are Zealand Pharma A/S, Bavarian Nordic A/S, Gubra A/S, FluoGuide A/S, ViroGates A/S and Saniona AB (publ).
-
What are the bottom 10 Clinical Trials companies in Denmark by Net Cash Used Provided By Financing Activities ?
The bottom 10 Clinical Trials companies in Denmark by Net Cash Used Provided By Financing Activities are Saniona AB (publ), ViroGates A/S, FluoGuide A/S, Gubra A/S, Bavarian Nordic A/S and Zealand Pharma A/S.
